Abstract
Two series of 17 tetrahydroquinoline compounds (2,4-DAr-THQs and DSQs), in which the 4-methoxy-3- hydroxyphenyl (isovanillin) structural unit is incorporated, were tested for their potential human tumor cell growth inhibitory effect on MCF-7, SKBR-3, PC3, HeLa and for non-tumor cells (primary culture of human dermis fibroblast – control cells) for the first time. The THQ 8 is an interesting model for antitumoral drugs, displaying cytotoxic activity against MCF7, SKBR3 or PC3 (IC50 7.99 - 16.14 μM) with the selectivity index 3.4 for MCF7.
Keywords: Functionalized tetrahydroquinolines, Isoeugenol, Antitumoral agents, Lewis acid-catalyzed imino Diels-Alder reactions, Tetrahydroquinoline compounds, Antimalarial, Antioxidant, Antimycobacterial, Polyfunctionalized quinoline, Anticancer agents, Hemi-synthetic, Synthetiq agents, Imino Diels Alder cycloaddition, Ketimine precursors, HeLa (cervical epithelial carcinoma), Adriamycin, Eugenol, Quinoline derivatives, Cytotoxic activities, Tumor cancer cells, Isatin, Anilines, Reference selectivity index
Letters in Drug Design & Discovery
Title: 4-Hydroxy-3-methoxyphenyl Substituted 3-methyl-tetrahydroquinoline Derivatives Obtained Through Imino Diels-Alder Reactions as Potential Antitumoral Agents
Volume: 7 Issue: 9
Author(s): Vladimir V. Kouznetsov, Diego R. Merchan Arenas, Francisco Arvelo, Josue S. Bello Forero, Felipe Sojo and Arturo Munoz
Affiliation:
Keywords: Functionalized tetrahydroquinolines, Isoeugenol, Antitumoral agents, Lewis acid-catalyzed imino Diels-Alder reactions, Tetrahydroquinoline compounds, Antimalarial, Antioxidant, Antimycobacterial, Polyfunctionalized quinoline, Anticancer agents, Hemi-synthetic, Synthetiq agents, Imino Diels Alder cycloaddition, Ketimine precursors, HeLa (cervical epithelial carcinoma), Adriamycin, Eugenol, Quinoline derivatives, Cytotoxic activities, Tumor cancer cells, Isatin, Anilines, Reference selectivity index
Abstract: Two series of 17 tetrahydroquinoline compounds (2,4-DAr-THQs and DSQs), in which the 4-methoxy-3- hydroxyphenyl (isovanillin) structural unit is incorporated, were tested for their potential human tumor cell growth inhibitory effect on MCF-7, SKBR-3, PC3, HeLa and for non-tumor cells (primary culture of human dermis fibroblast – control cells) for the first time. The THQ 8 is an interesting model for antitumoral drugs, displaying cytotoxic activity against MCF7, SKBR3 or PC3 (IC50 7.99 - 16.14 μM) with the selectivity index 3.4 for MCF7.
Export Options
About this article
Cite this article as:
V. Kouznetsov Vladimir, R. Merchan Arenas Diego, Arvelo Francisco, S. Bello Forero Josue, Sojo Felipe and Munoz Arturo, 4-Hydroxy-3-methoxyphenyl Substituted 3-methyl-tetrahydroquinoline Derivatives Obtained Through Imino Diels-Alder Reactions as Potential Antitumoral Agents, Letters in Drug Design & Discovery 2010; 7 (9) . https://dx.doi.org/10.2174/157018010792929577
DOI https://dx.doi.org/10.2174/157018010792929577 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Obesity, Diabetes and Atrial Fibrillation; Epidemiology, Mechanisms and Interventions
Current Cardiology Reviews Endothelial Dysfunction: Methods of Assessment and Application to Hypertension
Current Pharmaceutical Design Cell and Gene Therapies in Cardiovascular Disease with Special Focus on the No Option Patient
Current Gene Therapy Recent Advances for the Synthesis of Selenium-containing Small Molecules as Potent Antitumor Agents
Current Medicinal Chemistry Hypertension in Obstructive Sleep Apnoea
Vascular Disease Prevention (Discontinued) Getting Patients to Target- Implementing the Guidelines
Current Vascular Pharmacology Contribution of Mast Cells to Cerebral Aneurysm Formation
Current Neurovascular Research Alzheimer Disease and Type 2 Diabetes Mellitus: The Link to Tyrosine Hydroxylase and Probable Nutritional Strategies
CNS & Neurological Disorders - Drug Targets Novel Nanostructured Polymeric Carriers to Enable Drug Delivery for Cardiovascular Diseases
Current Pharmaceutical Design Subject Index to Volume 4
Current Drug Targets - Cardiovascular & Hematological Disorders Growing Collateral Arteries On Demand
Recent Patents on Cardiovascular Drug Discovery Therapeutic Potential of N-Acetylcysteine for Wound Healing, Acute Bronchiolitis, and Congenital Heart Defects
Current Drug Metabolism Regulation of Clusterin Gene Expression
Current Protein & Peptide Science Targeting MCP-1 to Reduce Vascular Complications of Obesity
Recent Patents on Cardiovascular Drug Discovery Effects of Glucagon-like Peptide-1 Receptor Agonists and Sodium-glucose Cotransporter 2 Inhibitors on Cardiorenal and Metabolic Outcomes in People Without Diabetes
Current Pharmaceutical Design ACE2 as a Key Target for Treatment of COVID-19 Related Cardiovascular Diseases: Current Progress and Prospect
Current Drug Targets Prevalence, Severity and Characteristics of Tardive Dyskinesia Among Schizophrenia Patients in an Israeli Psychiatric Center
Current Psychopharmacology Gestational Diabetes Mellitus Pharmacological Prevention and Treatment
Current Pharmaceutical Design HHT: A Rare Disease with A Broad Spectrum of Clinical Aspects
Current Pharmaceutical Design Impact of Renin-Angiotensin System in Hepatocellular Carcinoma
Current Cancer Drug Targets